K. Papp Clinical Research Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Waterloo ON Canada (1992)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2007
NCT00453271
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

K. Papp Clinical Research Inc. | K. Papp Clinical Research INC.

Active Ingredients

Drugs in Phase 4 Trials (1)

acetaminophen (tylenol) (1 trial)

Drugs in Phase 3 Trials (3)

adalimumab (humira) (1 trial)

calcipotriene (dovonex) (1 trial)

calcipotriol (1 trial)

Drugs in Phase 2 Trials (1)

nb-002 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthralgia (Phase 4)

Arthritis (Phase 4)

Onychomycosis (Phase 2)

Psoriasis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 5